Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200549857> ?p ?o ?g. }
- W4200549857 endingPage "39" @default.
- W4200549857 startingPage "18" @default.
- W4200549857 abstract "Among the C6-halo purine ribonucleosides, the readily accessible 6-chloro derivative has been known to undergo slow SNAr reactions with amines, particularly aryl amines. In this work, we show that in 0.1 M AcOH in EtOH, aryl amines react quite efficiently at the C6-position of 2',3',5'-tri-O-(t-BuMe2Si)-protected 6-chloropurine riboside (6-ClP-riboside), with concomitant cleavage of the 5'-silyl group. These two-step processes proceeded in generally good yields, and notably, reactions in the absence of AcOH were much slower and/or lower yielding. Corresponding reactions of 2',3',5'-tri-O-(t-BuMe2Si)-protected 6-ClP-riboside with alkyl amines proceeded well but without desilylation at the primary hydroxyl terminus. These differences are likely due to the acidities of the ammonium chlorides formed in these reactions, and the role of AcOH was not desilylation but possibly only purine activation. With 50% aqueous TFA in THF at 0 °C, cleavage of the 5'-silyl group from 2',3',5'-tri-O-(t-BuMe2Si)-protected N6-alkyl adenosine derivatives and from 6-ClP-riboside was readily achieved. Reactions of the 5'-deprotected 6-ClP-riboside with alkyl amines proceeded in high yields and under mild conditions. Because these complementary methodologies yielded N6-aryl and -alkyl adenosine derivatives containing a free 5'-hydroxyl group, a variety of product functionalizations were undertaken to yield N6,C5'-doubly modified nucleoside analogues." @default.
- W4200549857 created "2021-12-31" @default.
- W4200549857 creator A5010134206 @default.
- W4200549857 creator A5019069134 @default.
- W4200549857 creator A5071308090 @default.
- W4200549857 creator A5073373934 @default.
- W4200549857 creator A5074697800 @default.
- W4200549857 date "2021-12-14" @default.
- W4200549857 modified "2023-10-14" @default.
- W4200549857 title "General Approach to <i>N</i><sup>6</sup>,C5′-Difunctionalization of Adenosine" @default.
- W4200549857 cites W1497553243 @default.
- W4200549857 cites W1552047786 @default.
- W4200549857 cites W1564690392 @default.
- W4200549857 cites W1973720318 @default.
- W4200549857 cites W1973828453 @default.
- W4200549857 cites W1979787483 @default.
- W4200549857 cites W1981151354 @default.
- W4200549857 cites W1981693509 @default.
- W4200549857 cites W1982194431 @default.
- W4200549857 cites W1982577487 @default.
- W4200549857 cites W1983989802 @default.
- W4200549857 cites W1984747442 @default.
- W4200549857 cites W1985740073 @default.
- W4200549857 cites W1987229815 @default.
- W4200549857 cites W1991202602 @default.
- W4200549857 cites W1993444817 @default.
- W4200549857 cites W1994696454 @default.
- W4200549857 cites W2003957879 @default.
- W4200549857 cites W2006109101 @default.
- W4200549857 cites W2007554213 @default.
- W4200549857 cites W2013570284 @default.
- W4200549857 cites W2022618280 @default.
- W4200549857 cites W2023484412 @default.
- W4200549857 cites W2025131403 @default.
- W4200549857 cites W2025942079 @default.
- W4200549857 cites W2030423868 @default.
- W4200549857 cites W2031839594 @default.
- W4200549857 cites W2034990684 @default.
- W4200549857 cites W2037555251 @default.
- W4200549857 cites W2040831332 @default.
- W4200549857 cites W2042746076 @default.
- W4200549857 cites W2049587618 @default.
- W4200549857 cites W2074073537 @default.
- W4200549857 cites W2083061986 @default.
- W4200549857 cites W2084000111 @default.
- W4200549857 cites W2095453532 @default.
- W4200549857 cites W2124324529 @default.
- W4200549857 cites W2128251118 @default.
- W4200549857 cites W2136871045 @default.
- W4200549857 cites W2147954486 @default.
- W4200549857 cites W2160790360 @default.
- W4200549857 cites W2168993194 @default.
- W4200549857 cites W2171207011 @default.
- W4200549857 cites W2250396736 @default.
- W4200549857 cites W2313977648 @default.
- W4200549857 cites W2314809577 @default.
- W4200549857 cites W2316363983 @default.
- W4200549857 cites W2319604146 @default.
- W4200549857 cites W2326639051 @default.
- W4200549857 cites W2329403794 @default.
- W4200549857 cites W2330851308 @default.
- W4200549857 cites W2345736640 @default.
- W4200549857 cites W2486402433 @default.
- W4200549857 cites W2517202877 @default.
- W4200549857 cites W2561023353 @default.
- W4200549857 cites W2606939854 @default.
- W4200549857 cites W2765984174 @default.
- W4200549857 cites W2777055246 @default.
- W4200549857 cites W2781753848 @default.
- W4200549857 cites W2781763261 @default.
- W4200549857 cites W2787941881 @default.
- W4200549857 cites W2888118719 @default.
- W4200549857 cites W2896999321 @default.
- W4200549857 cites W2949843489 @default.
- W4200549857 cites W2951192254 @default.
- W4200549857 cites W2951356121 @default.
- W4200549857 cites W2951683849 @default.
- W4200549857 cites W2951733972 @default.
- W4200549857 cites W2952067087 @default.
- W4200549857 cites W2952475344 @default.
- W4200549857 cites W2988769843 @default.
- W4200549857 cites W3159035886 @default.
- W4200549857 cites W3175306060 @default.
- W4200549857 cites W4256104384 @default.
- W4200549857 cites W641636675 @default.
- W4200549857 doi "https://doi.org/10.1021/acs.joc.1c01587" @default.
- W4200549857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34905365" @default.
- W4200549857 hasPublicationYear "2021" @default.
- W4200549857 type Work @default.
- W4200549857 citedByCount "1" @default.
- W4200549857 countsByYear W42005498572022 @default.
- W4200549857 crossrefType "journal-article" @default.
- W4200549857 hasAuthorship W4200549857A5010134206 @default.
- W4200549857 hasAuthorship W4200549857A5019069134 @default.
- W4200549857 hasAuthorship W4200549857A5071308090 @default.
- W4200549857 hasAuthorship W4200549857A5073373934 @default.
- W4200549857 hasAuthorship W4200549857A5074697800 @default.
- W4200549857 hasConcept C155647269 @default.